184 related articles for article (PubMed ID: 10389752)
1. Expression of Smad proteins in human colorectal cancer.
Korchynskyi O; Landström M; Stoika R; Funa K; Heldin CH; ten Dijke P; Souchelnytskyi S
Int J Cancer; 1999 Jul; 82(2):197-202. PubMed ID: 10389752
[TBL] [Abstract][Full Text] [Related]
2. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
Lange D; Persson U; Wollina U; ten Dijke P; Castelli E; Heldin CH; Funa K
Int J Oncol; 1999 Jun; 14(6):1049-56. PubMed ID: 10339656
[TBL] [Abstract][Full Text] [Related]
3. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
[TBL] [Abstract][Full Text] [Related]
4. Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration.
Brodin G; ten Dijke P; Funa K; Heldin CH; Landström M
Cancer Res; 1999 Jun; 59(11):2731-8. PubMed ID: 10363999
[TBL] [Abstract][Full Text] [Related]
5. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
Pardali K; Kowanetz M; Heldin CH; Moustakas A
J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling.
Attisano L; Silvestri C; Izzi L; Labbé E
Mol Cell Endocrinol; 2001 Jun; 180(1-2):3-11. PubMed ID: 11451566
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
8. Smad regulation in TGF-beta signal transduction.
Moustakas A; Souchelnytskyi S; Heldin CH
J Cell Sci; 2001 Dec; 114(Pt 24):4359-69. PubMed ID: 11792802
[TBL] [Abstract][Full Text] [Related]
9. Intracellular signaling of osteogenic protein-1 through Smad5 activation.
Tamaki K; Souchelnytskyi S; Itoh S; Nakao A; Sampath K; Heldin CH; ten Dijke P
J Cell Physiol; 1998 Nov; 177(2):355-63. PubMed ID: 9766532
[TBL] [Abstract][Full Text] [Related]
10. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
[TBL] [Abstract][Full Text] [Related]
11. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer.
Jonson T; Gorunova L; Dawiskiba S; Andrén-Sandberg A; Stenman G; ten Dijke P; Johansson B; Höglund M
Genes Chromosomes Cancer; 1999 Jan; 24(1):62-71. PubMed ID: 9892110
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
[TBL] [Abstract][Full Text] [Related]
13. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
[TBL] [Abstract][Full Text] [Related]
14. Smad expression during kidney development.
Vrljicak P; Myburgh D; Ryan AK; van Rooijen MA; Mummery CL; Gupta IR
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F625-33. PubMed ID: 14656760
[TBL] [Abstract][Full Text] [Related]
15. New insights into TGF-beta-Smad signalling.
ten Dijke P; Hill CS
Trends Biochem Sci; 2004 May; 29(5):265-73. PubMed ID: 15130563
[TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
17. Frequency of Smad gene mutations in human cancers.
Riggins GJ; Kinzler KW; Vogelstein B; Thiagalingam S
Cancer Res; 1997 Jul; 57(13):2578-80. PubMed ID: 9205057
[TBL] [Abstract][Full Text] [Related]
18. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta signaling by Smad proteins.
Miyazono K
Cytokine Growth Factor Rev; 2000; 11(1-2):15-22. PubMed ID: 10708949
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]